ClinConnect ClinConnect Logo
Search / Trial NCT06201494

Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents

Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Dec 30, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the symptoms of bronchial asthma in children and adolescents who are experiencing their first asthma-related issues. While many people know about common asthma symptoms like coughing, shortness of breath, and wheezing, this study aims to explore less typical symptoms such as recurrent cough and pneumonia. By identifying these symptoms early, the trial hopes to help doctors provide better asthma treatment to young patients.

To be eligible for this trial, participants must be between 3 and 18 years old and have their first visit to a lung specialist due to symptoms like cough, chest tightness, or breathing difficulties. Unfortunately, those with other serious health conditions that could cause similar respiratory problems won't be able to participate. Children who join the trial can expect to receive thorough evaluations to help understand their symptoms better and to benefit from appropriate asthma management. This study is currently recruiting participants, so there’s an opportunity for families to get involved in important asthma research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Child 3 - 18 years old, first evaluation in pulmonary outpatient clinic for any of the following respiratory symptoms: cough, shortness of breath, chest tightness, wheezing, recurrent lower respiratory tract and lung infections, dyspnoea of any type, pathological listening findings.
  • Exclusion Criteria:
  • Other documented chronic respiratory, cardiovascular, neurological, genetic, infectious, metabolic disease, significant immaturity or other disease that may be accompanied by respiratory symptoms.

About Charles University, Czech Republic

Charles University, located in the Czech Republic, is a prestigious institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct innovative research that aims to improve patient outcomes and contribute to the global medical community. With a focus on ethical standards and rigorous scientific methodologies, Charles University collaborates with various stakeholders to explore new therapies and enhance healthcare practices, fostering a culture of excellence in clinical research.

Locations

Prague, , Czechia

Patients applied

0 patients applied

Trial Officials

Jana Tukova, MD,PhD

Principal Investigator

Charles University, Czech Republic First Faculty of Medicine, Prague

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported